These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27890898)

  • 1. Therapeutic oligonucleotides and delivery technologies: Research topics in Japan.
    Murakami M
    Drug Discov Ther; 2016; 10(5):234-235. PubMed ID: 27890898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake and intracellular trafficking of oligonucleotides.
    Juliano RL; Carver K
    Adv Drug Deliv Rev; 2015 Jun; 87():35-45. PubMed ID: 25881722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery system of therapeutic oligonucleotides.
    Asami Y; Yoshioka K; Nishina K; Nagata T; Yokota T
    Drug Discov Ther; 2016; 10(5):256-262. PubMed ID: 27890899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development.
    Andersson S; Antonsson M; Elebring M; Jansson-Löfmark R; Weidolf L
    Drug Discov Today; 2018 Oct; 23(10):1733-1745. PubMed ID: 29852223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can colorectal delivery technology provide a platform for enteral oligonucleotide-based therapeutics?
    Murakami M; Watanabe C
    Drug Discov Ther; 2016; 10(5):273-275. PubMed ID: 27890901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide therapeutics: chemistry, delivery and clinical progress.
    Sharma VK; Watts JK
    Future Med Chem; 2015; 7(16):2221-42. PubMed ID: 26510815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
    Plane G
    IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide delivery in cancer therapy.
    De Rosa G; De Stefano D; Galeone A
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1263-78. PubMed ID: 20977291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation.
    Scomparin A; Polyak D; Krivitsky A; Satchi-Fainaro R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1294-309. PubMed ID: 25916823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in oligonucleotide drug delivery.
    Roberts TC; Langer R; Wood MJA
    Nat Rev Drug Discov; 2020 Oct; 19(10):673-694. PubMed ID: 32782413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and Drug Metabolism Properties of Novel Therapeutic Modalities.
    Rock BM; Foti RS
    Drug Metab Dispos; 2019 Oct; 47(10):1097-1099. PubMed ID: 31399505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrins in oligonucleotide delivery.
    Redenti E; Pietra C; Gerloczy A; Szente L
    Adv Drug Deliv Rev; 2001 Dec; 53(2):235-44. PubMed ID: 11731029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of oligonucleotides and analogues: the oligonucleotide conjugate-based approach.
    Marlin F; Simon P; Saison-Behmoaras T; Giovannangeli C
    Chembiochem; 2010 Jul; 11(11):1493-500. PubMed ID: 20575132
    [No Abstract]   [Full Text] [Related]  

  • 15. Innovations in oligonucleotide drug delivery.
    Lysik MA; Wu-Pong S
    J Pharm Sci; 2003 Aug; 92(8):1559-73. PubMed ID: 12884243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of oligonucleotides with lipid nanoparticles.
    Wang Y; Miao L; Satterlee A; Huang L
    Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
    Juliano RL
    Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee SH; Castagner B; Leroux JC
    Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel reduction-sensitive modified polyethylenimine oligonucleotide vector.
    Yang S; Lee RJ; Yang X; Zheng B; Xie J; Meng L; Liu Y; Teng L
    Int J Pharm; 2015 Apr; 484(1-2):44-50. PubMed ID: 25698089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.